MarginsXMarginsX
Home › Markets › Health Care › KRMD

KORU Medical Systems Inc. Common Stock (DE) (KRMD)

KRMD trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.69
-0.27% on the day
Market cap
$160.1M
Micro cap
Revenue · 2025
$41.1M
+22.2% on 2024
Net income · 2025
-$2.6M
-6.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/704440/000116169726000052/0001161697-26-000052-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerKRMD on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000704440
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$41.1M
Net income-$2.6M
Operating income-$3.0M
Net margin-6.4%
Operating margin-7.2%
Revenue growth+22.2%
Cash$8.9M
Total assets$28.2M
P/E (computed)Net income was not positive
P/S (computed)3.9×

Warning signs

Cash runway
Cash-flow positive
$7.4M cash at September 30, 2026
Share count, 1 year
-6.4%
2025-11-12 to 2026-11-10 · -5.0% over 3 years
Going-concern doubt
No
10-Q filed November 10, 2026
Insider net buying, 12 months
$215K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-10
Cash and burn$7.4M cash; operating cash flow $111K a quarter.Report 2026-09-30
Shares outstanding43,375,176 (2026-11-10); 46,322,655 a year earlier; 45,669,362 three years earlier.Cover page 2026-11-10
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCherry Bekaert LLP, Tampa, Florida, United StatesPCAOB Form AP 2026-03-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $215K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$11.6M$218K-$883K$7.4M$332K$46.3M10-Q 2026-11-10
Q2 2026
2026-06-30
$12.0M$252K$216K$8.3MNo debt tags$45.1M10-Q 2026-08-05
Q1 2026
2026-03-31
$11.8M-$807K$15K$8.8MNo debt tags$43.3M10-Q 2026-05-06
Q4 2025
2025-12-31
$10.9M-$487K$1.1M$8.9MNo debt tags$41.1M10-K 2026-03-12
Q3 2025
2025-09-30
$10.4M-$778K$65K$8.5M$335K$39.1M10-Q 2026-11-10
Q2 2025
2025-06-30
$10.2M-$207K-$460K$8.1MNo debt tags$36.8M10-Q 2026-08-05
Q1 2025
2025-03-31
$9.6M-$1.2M-$237K$8.7M$137K$35.1M10-Q 2026-05-06
Q4 2024
2024-12-31
$8.8M-$1.6M$940K$9.6M$271K$33.6M10-K 2026-03-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM S-3 REGISTRATION STATEMENT
S-32026-11-16
Latest annual report
FORM 10-K ANNUAL REPORT FOR 12-31-2025
10-K2026-03-12
Latest quarterly / interim
FORM 10-Q QUARTERLY REPORT FOR 09-30-2026
10-Q2026-11-10
Latest current report
FORM 8-K CURRENT REPORT FOR 11-10-2026
8-K2026-11-10
Latest proxy
SCHEDULE 14A DEFINITIVE PROXY STATEMENT
DEF 14A2026-04-09

Source: SEC EDGAR submissions feed, 969 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+19.7%
1 month+23.3%
3 months+11.3%
Year to date-36.3%
1 year-14.9%
From 52-week high-43.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
ANIKAnika Therapeutics Inc.$12.92-3.58%$173.1M
KTWOK2 Capital Acquisition Corporation Class A Ordinary Share$10.13+0.05%$203.0M
PYPDPolyPid Ltd.$6.15-1.76%$124.9M
UTMDUtah Medical Products Inc.$72.36+0.54%$206.2M
PDEXPro-Dex Inc.$64.48-1.80%$206.3M
LUNGPulmonx Corporation$2.80-2.10%$121.9M
STIMNeuronetics Inc.$1.25-10.07%$120.6M
APYXApyx Medical Corporation$2.65-5.69%$111.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier